These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22248198

  • 1. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG.
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [Abstract] [Full Text] [Related]

  • 2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T.
    Kidney Blood Press Res; 2004 Feb; 27(2):88-95. PubMed ID: 14739577
    [Abstract] [Full Text] [Related]

  • 3. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.
    Ren Fail; 2007 Feb; 29(2):147-54. PubMed ID: 17365928
    [Abstract] [Full Text] [Related]

  • 4. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.
    Zhou Q, Wu S, Jiang J, Tian J, Chen J, Yu X, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie DI, Liu J, Xu X, Liang M, Hou F.
    Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256
    [Abstract] [Full Text] [Related]

  • 6. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
    Kir HM, Eraldemir C, Dervisoglu E, Caglayan C, Kalender B.
    Clin Lab; 2012 Sep; 58(5-6):495-500. PubMed ID: 22783580
    [Abstract] [Full Text] [Related]

  • 7. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 8. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.
    Ren Fail; 2008 Oct; 30(6):617-23. PubMed ID: 18661412
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [Abstract] [Full Text] [Related]

  • 10. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [Abstract] [Full Text] [Related]

  • 12. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
    Dağ A, Firat ET, Kadiroğlu AK, Kale E, Yilmaz ME.
    J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
    [Abstract] [Full Text] [Related]

  • 13. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A, Grekas DM.
    Am J Nephrol; 2007 Aug; 27(6):572-9. PubMed ID: 17804904
    [Abstract] [Full Text] [Related]

  • 14. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
    Borazan A, Aydemir S, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053
    [Abstract] [Full Text] [Related]

  • 15. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT, Hsu YJ, Chu NF, Lai CH, Chiu JS, Lin SH.
    J Nephrol; 2008 Dec; 21(5):744-52. PubMed ID: 18949730
    [Abstract] [Full Text] [Related]

  • 16. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D.
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [Abstract] [Full Text] [Related]

  • 17. Glucose concentration in the dialysate does not contribute to lipid profiles in patients undergoing CAPD.
    Li Z, Fengxian H.
    Ren Fail; 2011 Dec; 33(2):124-30. PubMed ID: 21332332
    [Abstract] [Full Text] [Related]

  • 18. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 19. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO, Pocan B, Borazan A, Ucar E, Kuvandik G, Ilikhan S, Demircan N, Ozer C, Kadayifci S.
    Ren Fail; 2008 May; 30(2):219-25. PubMed ID: 18300125
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B, Supasyndh O, Phantana-Angkul P, Ruangkanchanasetr P, Nata N, Chaiprasert A, Kanjanakul I, Choovichian P.
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.